Use of peptide asparginyl ligases (PALs) in generating alternative non-Ig protein-drug conjugates for cancer therapy
Past research on antibody–drug conjugates (ADCs) focused on protein site-specific modification as chemical conjugation lacks site-selectivity. And despite monoclonal antibodies being the most common immunotherapeutic agent, its applicability & functionality are limited by several restrictions. T...
Saved in:
| 主要作者: | |
|---|---|
| 其他作者: | |
| 格式: | Final Year Project |
| 語言: | English |
| 出版: |
Nanyang Technological University
2023
|
| 主題: | |
| 在線閱讀: | https://hdl.handle.net/10356/167167 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|